NCT03074513: Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
- State
- Under way
- Phase
- Phase 2
- People
- 133 taking part
- Started
- 3 Mar 2017
- Primary completion
- 30 Sep 2027
- Arms
- Treatment (atezolizumab, bevacizumab)
- Results
- None posted
- 3 Mar 2017: Trial started
- 8 Mar 2017: Trial registered